Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-022440

Chief Financial Officer acquired 6,099 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Smith Hunter C · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Exercise or conversion : show line 1 in the form +6,099 $6.80 $41,473 116,611 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-02 Exercise or conversion : show line 2 in the form Stock Options (Right to Buy) −6,099 91,401 D
Loading xslF345X05/tm267814-1_4seq1.xml…